Tech Company Financing Transactions
Agile Therapeutics Funding Round
On 1/4/2013, Agile Therapeutics raised $15 million in investment from Oxford Finance.
Transaction Overview
Company Name
Announced On
1/4/2013
Transaction Type
Debt
Amount
$15,000,000
Round
Undisclosed
Investors
Oxford Finance (Christopher Herr)
Proceeds Purpose
The company will use the additional funding to advance its product pipeline and prepare for commercialization activities.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
101 Poor Farm Rd.
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Website
Email Address
Overview
Agile Therapeutics is pharmaceutical company developing contraceptive healthcare products for women.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alfred Altomari
Chief Financial Officer
Scott Coiante
VP - General Counsel
Geoffrey Gilmore
Browse more venture capital transactions:
Prev: 1/4/2013: Discera venture capital transaction
Next: 1/4/2013: Docracy venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs